Results 261 to 270 of about 4,346,476 (378)

Antiprogestin-Releasing Intrauterine Devices: A Novel Approach to Endometrial Contraception [PDF]

, 2000
Nihar R. Nayak, Ov D. Slayden, Kristof Chwalisż, Matti Lehtinen, Robert Brenner   +4 more
openalex   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 16 No. 1 [PDF]

, 1980

core   +1 more source

Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A

Contraception, 2016
P. Rowe, T. Farley, Alexandre Peregoudov, G. Piaggio, S. Boccard, S. Landoulsi, O. Meirik   +6 more
semanticscholar   +1 more source

The Price of Suffering? Monetary Compensation Claims for the Danish State's Postcolonial Child Displacement in Greenland

PoLAR: Political and Legal Anthropology Review, Volume 48, Issue 2, November 2025.
ABSTRACT This article explores how the cost of harm and suffering are measured and monetized in contemporary compensation claims for postcolonial child removals from Greenland to Denmark. I ask how painful past experiences can be translated into legal compensation claims and which forms of harm remain uncounted and, therefore, economically worthless. I
Saana Hansen
wiley   +1 more source

Intrauterine device management by nurses in Primary Health Care. [PDF]

Rev Bras Enferm
Silva EKRD, Guedes HM, Nascimento DDGD, Souza AS, Duarte SJH.   +4 more
europepmc   +1 more source

Incidence of GLP‐1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011–2022: a retrospective open cohort study

Medical Journal of Australia, Volume 223, Issue 7, Page 365-371, October 2025.
Abstract Objective To examine longitudinal changes in the initial prescribing of glucagon‐like peptide 1 (GLP‐1) receptor agonists for women of reproductive age in Australia; to determine whether contraception recommendations are being followed; and to estimate the frequency of pregnancy among women using GLP‐1 receptor agonists.
Kailash Thapaliya, Arianne Sweeting, Kirsten I Black, Amanda Poprzeczny, Danielle Mazza, Luke E Grzeskowiak   +5 more
wiley   +1 more source

A case of recurrent fixed drug eruption triggered by a hormonal intrauterine device. [PDF]

JAAD Case Rep
Awad N, Fontaine D, Schiele K, Regmi A, Sriharan A, Fragoso NM.   +5 more
europepmc   +1 more source

Cytological Studies on the Touch Smears of Patients Wearing Intrauterine Devices

, 1980
Yoshino ABE, Sadayuki UMEHARA, Hidetaka HAYASHIDA, Takayasu SHIRAISHI, Yoshiki Matsuo, Megumu Fushimi, Sadamu Noda   +6 more
openalex   +2 more sources

Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report

American Journal of Hematology, Volume 100, Issue 10, Page 1813-1827, October 2025.
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies.
Hanny Al‐Samkari, Raj S. Kasthuri, Hans‐Jurgen Mager, Jenny Y. Zhou, Marcelo M. Serra, Bethany T. Samuelson‐Bannow, Layla N. Van Doren, Jay F. Piccirillo, Marianne S. Clancy, Keith R. McCrae, Sonia M. Thomas, Antoni Riera‐Mestre, Allyson M. Pishko, Sarah Sewaralthahab, James R. Gossage, Vivek N. Iyer, Cedric Hermans, Adrienne Hammill, Ingrid Winship, Meir Mei‐Zahav, Annette von Drygalski, Scott Olitsky, Marie E. Faughnan   +22 more
wiley   +1 more source

Virtual Reality for Analgesia During Intrauterine Device Insertion: Randomized Controlled Trial.

JMIR Serious Games
Higgins C, Zecena Morales C, Hocking J, Tyson K, Leung C, Larmour L, Leong P, Vollenhoven B.   +7 more
europepmc   +1 more source